While studying the Tau protein, which masses into tangles in diseased brains, Wischik came upon an accidental discovery.
In 1988 he tried to dye these tangles in a test tube with methylene blue, an old malaria drug, in order to make the tangles more visible. Instead, the tangles dissolved.
This surprising result, lead to Rember, a drug his company TauRx created two decades later. Rember may be the silver bullet in significantly reducing memory loss among those with Alzheimer’s.
Read more here.